Clinical trial

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

NCT00897650

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

GENETIC · Unmapped registry intervention DNA/RNA sequencing and expression levels Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention Protein expression analysis Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Lung tumor biopsy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Blood sample Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2005-12-01

PhaseN/A

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

DNA/RNA sequencing and expression levelsGENETIC

Protein expression analysisGENETIC

Lung tumor biopsyPROCEDURE

Blood samplePROCEDURE

Sponsors & collaborators

Vanderbilt-Ingram Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00897650 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.